Navigation Links
Revealing the regulating mechanism behind signal transduction in the brain
Date:9/19/2008

Leuven, Belgium Our brain consists of billions of cells that continually transmit signals to each other. This dynamic process − which enables us to learn, remember, and so much more − works only when the brain cells make contact correctly, or, in other words, when there is a good 'synapse'. An essential element in this process is a controlled protein production along with the synapse. VIB researchers connected to the Center for Human Genetics (K.U.Leuven) are now discovering how the Fragile X protein (FMRP) ensures that protein production is controlled at synapse and regulated by brain activity. Their findings are being published in the authoritative scientific journal Cell.

Fathoming the brain

Our 'gray matter' has yet to divulge all its secrets. For example, we do not yet fully understand how we are able to learn and remember things. We do know that dendrites and axons − the offshoots of brain cells − play a crucial role by making contact with each other in so-called synapses, through which signals are transmitted between different brain cells. Moreover, for properly functioning brain activity at a synapse, the right proteins must be present in the right concentrations. It has been known for some time that the brain's cells are able to produce proteins directly at the place where they are needed. But exactly how the subtle regulation of this process works is still to be discovered.

FMRP: controlling protein production

Claudia Bagni (VIB, K.U.Leuven, University of Rome Tor Vergata) has been studying the FMRP protein for years now. The absence of FMRP leads to the Fragile X syndrome, a mental handicap afflicting a thousand Belgians. In this particular syndrome, the synapses are not well-formed. So, it is no surprise that FMRP plays an important role in the development and functioning of the brain. The researchers have already shown that FMRP suppresses protein production, but how has remai
'/>"/>

Contact: Sooike Stoops
info@vib.be
329-244-6611
VIB (the Flanders Institute for Biotechnology)
Source:Eurekalert

Page: 1 2

Related biology technology :

1. Human Trial Results Show Plant Extract Tops Drug at Regulating Blood Sugar Levels; Huge Market Seen for Newly Developed Food Additive Emulin™
2. Gladstone scientists uncover potential mechanism of memory loss in Alzheimers disease
3. Cleveland Clinic-Led Research Uncovers New Mechanism That Heightens Risk of Heart Disease
4. Mechanism for the in-vivo transport of siRNA
5. Agendia Acquires Rights to the Discovery of a Major Drug Resistance Mechanism in Breast Cancer Potentially Leading to a Herceptin(R) Sensitivity Test
6. FDA Approves New Mechanism of Action Labeling for Ranexa(R)
7. Growing old together: Yeast, worms and people may age by similar mechanisms
8. Real-time observation of the DNA-repair mechanism
9. ImQuest Awarded SBIR Grant to Define the Mechanism of Action of Their Lead Anti-HIV Therapeutic Compound IQP-0410
10. Study reveals principles behind stability and electronic properties of gold nanoclusters
11. Scientists peel away the mystery behind golds catalytic prowess
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... ... ... R-Biopharm is proud to announce the RIDASCREEN® Gliadin Competitive ... been accepted by AOAC International as Official First Action method. The AOAC Official ... R5 Competitive ELISA,” based on a specific monoclonal antibody to potentially celiac toxic ...
(Date:7/30/2015)... ATLANTA , July 30, 2015 ... leaders to the 2015 AACC Annual Meeting & ... from July 26–30. The meeting showcased revolutionary ... improves the ability of healthcare providers to diagnose ... get effective medical treatment. As ...
(Date:7/30/2015)... USA (PRWEB) , ... July 30, 2015 , ... ... microsystems, has appointed Francois Vieillard as Sales & Marketing Director. , With ... Francois Vieillard will be responsible for reinforcing Tronics’ business development activities worldwide. He ...
(Date:7/30/2015)... According to a new market ... PB/PK, PKPD, Trial Design, Toxicity Prediction, In-house, Contract Service), ... by End Users - Global Forecast to 2020", published ... USD 2,107.99 million by 2020 from USD 1,034.93 million ... Browse more than 75 ...
Breaking Biology Technology:RIDASCREEN® Competitve Gliadin Receives AOAC Official First Action Status 2Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 2Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 3Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 4Tronics appoints Francois Vieillard as Sales and Marketing Director 2Biosimulation Market Worth 2,107.99 Million USD by 2020 2Biosimulation Market Worth 2,107.99 Million USD by 2020 3Biosimulation Market Worth 2,107.99 Million USD by 2020 4
... N.Y., March 20 XTL,Biopharmaceuticals Ltd. (Nasdaq: ... pre-clinical program in Hepatitis C focused on the ... Inc. Presidio,is a private biotechnology company focused on ... backed by some of the,most prominent investors in ...
... Corporation, a leading,provider of fully integrated imaging ... of its real-time patient and resource,scheduler software, ... staff, rooms with drag and drop ease,delivering ... ROI., A free CardioSchedule Information Kit ...
... March 20 Amsterdam Molecular,Therapeutics (Euronext: AMT), a ... announced that AMT,s Supervisory Board has decided to ... Board at its Annual,General Meeting of shareholders on ... of TomTom (Euronext Amsterdam: TOM2), and has been,instrumental ...
Cached Biology Technology:XTL Biopharmaceuticals Signs $108 Million Deal for the Licensing of its Pre- Clinical Program in Hepatitis C to Presidio Pharmaceuticals 2XTL Biopharmaceuticals Signs $108 Million Deal for the Licensing of its Pre- Clinical Program in Hepatitis C to Presidio Pharmaceuticals 3XTL Biopharmaceuticals Signs $108 Million Deal for the Licensing of its Pre- Clinical Program in Hepatitis C to Presidio Pharmaceuticals 4LUMEDX Updates Real-Time Patient and Resource Scheduler for Healthcare Systems 2Amsterdam Molecular Therapeutics to Appoint Alexander Ribbink to Supervisory Board 2Amsterdam Molecular Therapeutics to Appoint Alexander Ribbink to Supervisory Board 3
(Date:7/8/2015)... SAN DIEGO , July 8, 2015 /PRNewswire/ ... of cell-free molecular diagnostics, today announced the launch ... of the Company,s Precision Cancer Monitoring℠ (PCM) technology ... patients receiving one or a combination of the ... and Opdivo® (nivolumab), a PD-1 inhibitor. The 50-patient ...
(Date:7/7/2015)... July 7, 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... growing mobile commerce market announces a revised version of one of ... commercial will air on CNBC in New York ... and San Francisco metro areas.    ... on Wocket,s ability to replace all the cards in your wallet ...
(Date:6/30/2015)... 30, 2015 To bolster its efforts and commitment ... announced today the addition of two new team members. ... advisor and David Raviv will act as head ... Corp.,s commitment to providing the most secure solutions for the ... co-founded Layer 7 Technologies, a provider of security and management ...
Breaking Biology News(10 mins):Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3
... A major initiative to create alternative nesting sites for the ... help protect juvenile salmon and steelhead in the Columbia River ... nesting site at Crump Lake in southern Oregon, which was just ... more than 135 nesting pairs of Caspian terns, as well as ...
... called for Europe to invest more funds into the study ... role in the function of human cells and which are ... to Alzheimer,s. Common lipids such as cholesterol are known ... cells and tissues, but human cells contain thousands of different ...
... Belfast is appealing for help from the public in looking ... Activities such as aquaculture, shipping and recreational boating have led ... Now Queen,s is attempting to find out exactly where and how ... this it is asking for help from the public to record ...
Cached Biology News:Project succeeding to relocate Caspian terns 2Project succeeding to relocate Caspian terns 3Project succeeding to relocate Caspian terns 4Project succeeding to relocate Caspian terns 5Project succeeding to relocate Caspian terns 6Europe-wide investment in lipid research will help tackle disease, says new report 2Queen's marine biologist investigates aliens beneath the waves 2
...
... antibody-based immunoaffinity matrices, such as Sepharose ... without compromising antigen-antibody reactivity, the need ... has precluded the application of these ... CHEMICON Re-Blot Plus Western Blot Mild ...
Applications: Western blotting ...
Applications: Western blotting ...
Biology Products: